​

Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 113.29% institutional investors, 1.21% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.79% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.32% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical113.29%1.21%-14.50%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustrySpecialty & Generic Drug Manufacturers Stocks36.60%14.08%49.32%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.45M16.79%$118.89M
Vanguard group2.26M7.15%$104.46M
Janus henderson group1.83M5.76%$60.36M
State street1.77M5.46%$38.67M
Principal financial group1.51M4.67%$33.04M
Massachusetts financial services co /ma/1.49M4.58%$32.44M
Renaissance1.41M4.34%$30.73M
Vanguard capital management1.38M4.24%$30.01M
Eventide asset management1.36M4.19%$29.69M
Rubric capital management lp1.28M3.99%$46.32M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management410.18K4.75%$8.95M
Goldentree asset management lp744.89K1.56%$26.92M
Ballast asset management, lp108.78K1.03%$2.37M
Third avenue management222.74K0.81%$4.86M
Summerhaven investment management23.91K0.67%$923.73K
Watershed asset management14.97K0.48%$541.91K
Knott david m jr39.00K0.47%$850.98K
Rubric capital management lp1.28M0.42%$46.32M
Eventide asset management1.36M0.42%$29.69M
Nverses capital5.57K0.31%$201.78K

Top Buyers

HolderShares% AssetsChange
Goldentree asset management lp744.89K1.56%744.89K
Propel bio management410.18K4.75%410.18K
Janus henderson group1.83M0.03%377.07K
Millennium management736.92K0.01%376.10K
State street1.77M0.00%243.36K

Top Sellers

HolderShares% AssetsChange
Fuller & thaler asset management598.54K0.04%-1.03M
Invesco1.26M0.00%-621.46K
Arrowstreet capital, limited partnership83.47K0.00%-538.45K
Sixth street partners management company---486.60K
Two sigma investments, lp106.70K0.00%-483.41K

New Positions

HolderShares% AssetsChangeValue
Goldentree asset management lp744.89K1.56%744.89K$26.92M
Propel bio management410.18K4.75%410.18K$8.95M
Point72 asset management114.01K0.00%114.01K$4.13M
Norges bank112.50K0.00%112.50K$5.21M
Simplify asset management93.52K0.03%93.52K$2.04M

Sold Out

HolderChange
Stephens consulting-1.00
Davis capital management-2.00
Lindbrook capital-2.00
Mendota financial group-4.00
Flagship harbor advisors-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026242-14.79%36,776,415-7.21%1130.74%123-26.35%917.06%
Jun 30, 20262794.49%39,582,6554.22%1230.86%1627.28%8510.39%
Mar 31, 2026158-43.17%16,783,792-54.78%520.38%85-37.04%45-58.72%
Dec 31, 2025189-22.54%28,523,231-22.90%900.67%83-36.15%77-10.47%
Sep 30, 20252327.91%36,812,0797.39%1151.00%12314.95%846.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.96M6.32%1.18K
FullerThaler Beh Small-Cap Equity SMA1.56M4.81%130.70K
FullerThaler Behavioral Small-Cap Equity1.56M4.81%130.70K
FullerThaler Behavioral Sm-Cp Eq R61.56M4.80%130.70K
Eventide Gilead N1.34M4.13%-
Vanguard US Total Market Shares ETF993.93K3.09%-
Vanguard Morn Total Stk Mkt Idx Investor977.96K3.02%29.30K
Vanguard Total Stock Mkt Idx Inv977.96K3.02%29.30K
Vanguard MStar Total Stk Mkt Idx Invest977.96K3.00%-
iShares Russell 2000 ETF825.49K2.66%-

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Freund John Gordon-Sell$681.00
May 15, 2026Freund John Gordon-Sell$142.55K
May 13, 2026Lurker Nancy-Sell$161.86K
May 11, 2026BOHLIN GAREN G-Sell$323.49K
Mar 18, 2026Dieter David EVP & General CounselSell$488.10K

Insider Transactions Trends


DateBuySell
2026 Q2-4
2026 Q1-3
2025 Q4-6
2025 Q3-6
2025 Q2-1

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 113.29%, followed by 1.21% insiders and -14.50% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 36.60%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.45M shares, 16.79%), Vanguard group (2.26M shares, 7.15%), and Janus henderson group (1.83M shares, 5.76%). Together, they hold 29.69% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Propel bio management is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 4.75% of its assets in 410.18K Collegium Pharmaceutical shares, valued at 8.95M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.32% of its total shares outstanding invested in 1.96M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools